Niedwiecki et al. examined the serum miR-200c levels in patients with two different BC subtypes and observed that TNBC patients had lower miRNA-200c levels than the ER/PR positive group as a whole (Niedzwiecki et al., 2018). The gene discussed is ESR1; the disease is breast cancer.